Heparin plus a glycoprotein IIb/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial

Publication | Closed Access

DOI

447

Citations

References

2011

Year

Gregg W. Stone, Bernhard Witzenbichler, Giulio Guagliumi, Jan Z. Peruga, Bruce R. Brodie, Dariusz Dudek, Ran Kornowski, Franz Hartmann, Bernard J. Gersh, Stuart Pocock,

The Lancet

ThrombosisPercutaneous Coronary InterventionCardiovascular DiseasePaclitaxel-eluting StentsMyocardial InfarctionPharmacotherapyPlatelet AntagonistMedicineAnticoagulantCardiologyCoronary Artery DiseaseAcute Myocardial InfarctionBare-metal Stents